These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28971756)

  • 1. Hyphenated Mass Spectrometry Techniques in the Diagnosis of Amyloidosis.
    Spodzieja M; Rodziewicz-Motowidło S; Szymanska A
    Curr Med Chem; 2019; 26(1):104-120. PubMed ID: 28971756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirming the Diagnosis of Amyloidosis.
    Wisniowski B; Wechalekar A
    Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical proteomics for diagnosis and typing of systemic amyloidoses.
    Brambilla F; Lavatelli F; Merlini G; Mauri P
    Proteomics Clin Appl; 2013 Jan; 7(1-2):136-43. PubMed ID: 23184874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New Insights into Diagnosis and Pathogenesis of Amyloidosis by Mass Spectrometric Analysis].
    Tasaki M; Obayashi K; Ando Y
    Rinsho Byori; 2016 Jun; 64(6):675-679. PubMed ID: 30695322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Laboratory Test Using Proteomics: The Usefulness of Proteomic Techniques for Amyloid Typing].
    Tasaki M; Obayashi K; Ando Y
    Rinsho Byori; 2015 Aug; 63(8):980-5. PubMed ID: 26638436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic typing of amyloid deposits in systemic amyloidoses.
    Lavatelli F; Vrana JA
    Amyloid; 2011 Dec; 18(4):177-82. PubMed ID: 22080761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.
    Leung N; Nasr SH; Sethi S
    Blood; 2012 Oct; 120(16):3206-13. PubMed ID: 22948045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.
    Gilbertson JA; Theis JD; Vrana JA; Lachmann H; Wechalekar A; Whelan C; Hawkins PN; Dogan A; Gillmore JD
    J Clin Pathol; 2015 Apr; 68(4):314-7. PubMed ID: 25637636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic amyloidosis from A (AA) to T (ATTR): a review.
    Muchtar E; Dispenzieri A; Magen H; Grogan M; Mauermann M; McPhail ED; Kurtin PJ; Leung N; Buadi FK; Dingli D; Kumar SK; Gertz MA
    J Intern Med; 2021 Mar; 289(3):268-292. PubMed ID: 32929754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of Mass Spectrometry-Based Targeted Analysis for Amyloid Proteins.
    Park J; Lee GY; Choi JO; Jeon ES; Kim K; Kim JS; Lee SY
    Proteomics Clin Appl; 2018 May; 12(3):e1700106. PubMed ID: 29266842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics in molecular diagnosis: typing of amyloidosis.
    Loo D; Mollee PN; Renaut P; Hill MM
    J Biomed Biotechnol; 2011; 2011():754109. PubMed ID: 22131817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
    Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
    Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of systemic amyloid deposits by mass spectrometry.
    Murphy CL; Wang S; Williams T; Weiss DT; Solomon A
    Methods Enzymol; 2006; 412():48-62. PubMed ID: 17046651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
    Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
    BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis.
    Sethi S; Dasari S; Amin MS; Vrana JA; Theis JD; Alexander MP; Kurtin PJ
    Kidney Int; 2017 Apr; 91(4):964-971. PubMed ID: 28139293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis.
    Dasari S; Amin MS; Kurtin PJ; Vrana JA; Theis JD; Grogg KL; Alexander MP; Nasr SH; Fervenza FC; Leung N; Sethi S
    Kidney Int; 2016 Sep; 90(3):658-64. PubMed ID: 27262366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amyloidosis--diagnostic difficulties. A case report of localized amyloidosis].
    Maślińska M; Legatowicz-Koprowska M; Przygodzka M
    Wiad Lek; 2011; 64(3):202-7. PubMed ID: 22335145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis.
    Aoki M; Kang D; Katayama A; Kuwahara N; Nagasaka S; Endo Y; Terasaki M; Kunugi S; Terasaki Y; Shimizu A
    Clin Exp Nephrol; 2018 Aug; 22(4):871-880. PubMed ID: 29372474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
    Tasaki M; Obayashi K; Ueda M; Ando Y
    Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.